Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC.

Front Oncol · 2025 · PMC12127343 · PMID 40458723

Europe PMC DOI

hedged sentence

0.2840

closest p · 5.7× alpha

0.2840

boldest claim

The sentences

did not reach statistical significancep = 0.284not close (p > 0.1)

33.3%), this difference did not reach statistical significance ( p = 0.284).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.